UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 130

Sortiert nach

CCAR1 and CCAR2 as gene chameleons with antagonistic duality: Preclinical, human translational, and mechanistic basis

Cancer science, 2020-10, Vol.111 (10), p.3416-3425

2020

Link zum Volltext

Verfügbarkeit prüfen

A-Z of Epigenetic Readers: Targeting Alternative Splicing and Histone Modification Variants in Cancer

Cancers, 2024-03, Vol.16 (6), p.1104

2024

Link zum Volltext

Verfügbarkeit prüfen

Histone Acyl Code in Precision Oncology: Mechanistic Insights from Dietary and Metabolic Factors

Nutrients, 2024-01, Vol.16 (3), p.396

2024

Link zum Volltext

Verfügbarkeit prüfen

Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly

Molecular cancer, 2011-05, Vol.10 (1), p.68-68, Article 68

2011

Link zum Volltext

Verfügbarkeit prüfen

Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors

Current topics in medicinal chemistry, 2016-01, Vol.16 (7), p.714

2016

Link zum Volltext

Verfügbarkeit prüfen

S318 Optimized Lower Dose Combinations of Sulindac Plus Erlotinib Sustained Antitumor Efficacy and Reduced Toxicity in a Preclinical Model of FAP

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S138-S138

2021

Link zum Volltext

Verfügbarkeit prüfen

BRD9 Inhibition by Natural Polyphenols Targets DNA Damage/Repair and Apoptosis in Human Colon Cancer Cells

Nutrients, 2022-10, Vol.14 (20), p.4317

2022

Link zum Volltext

Verfügbarkeit prüfen

Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells

Clinical epigenetics, 2011-10, Vol.3 (1), p.4-4, Article 4

2011

Link zum Volltext

Verfügbarkeit prüfen

Deacetylase Plus Bromodomain Inhibition Downregulates ERCC2 and Suppresses the Growth of Metastatic Colon Cancer Cells

Cancers, 2021-03, Vol.13 (6), p.1438

2021

Link zum Volltext

Verfügbarkeit prüfen

Development of a murine colonoscopic polypectomy model (with videos)

Gastrointestinal endoscopy, 2016-06, Vol.83 (6), p.1272-1276

2016

Link zum Volltext

Verfügbarkeit prüfen

Targeting ACE2-BRD4 crosstalk in colorectal cancer and the deregulation of DNA repair and apoptosis

NPJ precision oncology, 2023-02, Vol.7 (1), p.20-20, Article 20

2023

Link zum Volltext

Verfügbarkeit prüfen

Discovery of adamantane based highly potent HDAC inhibitors

Bioorganic & medicinal chemistry letters, 2013-05, Vol.23 (9), p.2532-2537

2013

Link zum Volltext

Verfügbarkeit prüfen

Metabolomics of Acute vs. Chronic Spinach Intake in an Apc-Mutant Genetic Background: Linoleate and Butanoate Metabolites Targeting HDAC Activity and IFN-γ Signaling

Cells (Basel, Switzerland), 2022-02, Vol.11 (3), p.573

2022

Link zum Volltext

Verfügbarkeit prüfen

Sensing Accident-Prone Features in Urban Scenes for Proactive Driving and Accident Prevention

IEEE transactions on intelligent transportation systems, 2023-09, Vol.24 (9), p.1-14

2023

Link zum Volltext
IEEE_Xplore

Abstract 3477: Dietary polyphenols as epigenetic ‘reader' inhibitors

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.3477-3477

2020

Link zum Volltext

Verfügbarkeit prüfen

Hybrid Intrusion Detection System for Private Cloud: A Systematic Approach

Procedia computer science, 2015, Vol.48, p.325-329

2015

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and cytotoxic activity of 3- O-acyl/3-hydrazine /2-bromo/20,29-dibromo betulinic acid derivatives

Bioorganic & medicinal chemistry letters, 2004-08, Vol.14 (15), p.4087-4091

2004

Link zum Volltext

Verfügbarkeit prüfen

Heterocyclic Analogs of Sulforaphane Trigger DNA Damage and Impede DNA Repair in Colon Cancer Cells: Interplay of HATs and HDACs

Molecular nutrition & food research, 2018-09, Vol.62 (18), p.e1800228-n/a

2018

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2106: Combined deacetylase and bromodomain inhibition downregulates ERCC2 and suppresses growth of metastatic colon cancer cells

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.2106-2106

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5074: Optimizing erlotinib plus sulindac dosing regimens in a preclinical model of FAP

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.5074-5074

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract A013: Metabolomics of acute vs. chronic spinach intake in an Apc-mutant genetic background: linoleate and butanoate metabolites targeting HDAC activity and IFN-γ signaling

Cancer prevention research (Philadelphia, Pa.), 2022-12, Vol.15 (12_Supplement_2), p.A013-A013

2022

Link zum Volltext

Verfügbarkeit prüfen

Abstract 21: Optimization of dosing regimens of sulindac in combination with erlotinib for small intestine and colorectal cancer prevention

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.21-21

2020

Link zum Volltext

Verfügbarkeit prüfen

Acute Coronary Syndrome - A Comparative Study Of Admissions & Outcomes During Covid -19 Pandemic

Indian heart journal, 2022-11, Vol.74, p.S44-S45

2022

Link zum Volltext

Verfügbarkeit prüfen

Acetylation of CCAR2 Establishes a BET/BRD9 Acetyl Switch in Response to Combined Deacetylase and Bromodomain Inhibition

Cancer research (Chicago, Ill.), 2019-03, Vol.79 (5), p.918-927

2019

Link zum Volltext

Verfügbarkeit prüfen

Metabolism as a key to histone deacetylase inhibition

Critical reviews in biochemistry and molecular biology, 2011-06, Vol.46 (3), p.181-199

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 130

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(99)
Mit Volltextzugriff
(125)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(71)
Life Sciences & Biomedicine
(49)
Humans
(28)
Technology
(21)
Physical Sciences
(17)
Cell Line, Tumor
(15)
Animals
(13)
Oncology
(13)
Engineering
(12)
Pharmacology & Pharmacy
(12)
Cancer
(11)
Chemistry
(11)
Antineoplastic Agents - Pharmacology
(10)
Male
(10)
Materials Science
(10)
Apoptosis
(9)
Chemistry, Medicinal
(9)
Histone Deacetylases - Metabolism
(9)
Colon Cancer
(8)
Histone Deacetylase Inhibitors - Pharmacology
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

CCAR1 and CCAR2 as gene chameleons with antagonistic duality: Preclinical, human translational, and mechanistic basis

A-Z of Epigenetic Readers: Targeting Alternative Splicing and Histone Modification Variants in Cancer

Histone Acyl Code in Precision Oncology: Mechanistic Insights from Dietary and Metabolic Factors

Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly

Histone and Non-Histone Targets of Dietary Deacetylase Inhibitors

S318 Optimized Lower Dose Combinations of Sulindac Plus Erlotinib Sustained Antitumor Efficacy and Reduced Toxicity in a Preclinical Model of FAP

BRD9 Inhibition by Natural Polyphenols Targets DNA Damage/Repair and Apoptosis in Human Colon Cancer Cells

Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells

Deacetylase Plus Bromodomain Inhibition Downregulates ERCC2 and Suppresses the Growth of Metastatic Colon Cancer Cells

Development of a murine colonoscopic polypectomy model (with videos)

Targeting ACE2-BRD4 crosstalk in colorectal cancer and the deregulation of DNA repair and apoptosis

Discovery of adamantane based highly potent HDAC inhibitors

Metabolomics of Acute vs. Chronic Spinach Intake in an Apc-Mutant Genetic Background: Linoleate and Butanoate Metabolites Targeting HDAC Activity and IFN-γ Signaling

Sensing Accident-Prone Features in Urban Scenes for Proactive Driving and Accident Prevention

Abstract 3477: Dietary polyphenols as epigenetic ‘reader' inhibitors

Hybrid Intrusion Detection System for Private Cloud: A Systematic Approach

Synthesis and cytotoxic activity of 3- O-acyl/3-hydrazine /2-bromo/20,29-dibromo betulinic acid derivatives

Heterocyclic Analogs of Sulforaphane Trigger DNA Damage and Impede DNA Repair in Colon Cancer Cells: Interplay of HATs and HDACs

Abstract 2106: Combined deacetylase and bromodomain inhibition downregulates ERCC2 and suppresses growth of metastatic colon cancer cells

Abstract 5074: Optimizing erlotinib plus sulindac dosing regimens in a preclinical model of FAP

Abstract A013: Metabolomics of acute vs. chronic spinach intake in an Apc-mutant genetic background: linoleate and butanoate metabolites targeting HDAC activity and IFN-γ signaling

Abstract 21: Optimization of dosing regimens of sulindac in combination with erlotinib for small intestine and colorectal cancer prevention

Acute Coronary Syndrome - A Comparative Study Of Admissions & Outcomes During Covid -19 Pandemic

Acetylation of CCAR2 Establishes a BET/BRD9 Acetyl Switch in Response to Combined Deacetylase and Bromodomain Inhibition

Metabolism as a key to histone deacetylase inhibition

Suchergebnisse filtern